Literature DB >> 6254358

Epidemic outbreaks of adenovirus 7 with special reference to the pathogenicity of adenovirus genome type 7b.

G Wadell, T M Varsányi, A Lord, R N Sutton.   

Abstract

Adenovirus type 7 (Ad 7) is the serotype among the 36 recognized adenovirus types which most frequently has been associated with severe illness. Three different epidemic patterns of Ad 7 infection can be distinguished: 1) the first appears during the winter among infants with median age below two years, has characteristic symptoms of high fever and pneumonia and an outcome that may be fatal: 2) the second appears in the fall among children with median age seven years, has characteristic symptoms of high fever, pneumonia, abdominal symptoms and meningism and an outcome that is favorable; 3) and the third has been seen as acute respiratory disease among military recruits. In the United States, the last mentioned outbreaks require prophylaxis in the form of a live enteric-coated vaccine. DNA restriction site mapping demonstrated the occurrence of three distinct viral entities of Ad 7, which have been designated Ad 7 prototype, Ad 7a (the vaccine strain) and the Ad 7b genome type. In the present study, 36 isolates obtained from outbreaks with the first and the second epidemic patterns were analyzed by restriction endonucleases Bam HI and Sma I. All were identified as the newly recognized Ad 7b genome type. It is concluded that this genome type is responsible for a large portion of the severe infections caused by Ad 7. The epidemic nature of Ad 7 and the severe illness noted among infants indicate that vaccination of institutionalized infants could be considered during years when Ad 7 epidemics appear.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6254358     DOI: 10.1093/oxfordjournals.aje.a113034

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  39 in total

1.  Open reading frame E3-10.9K of subspecies B1 human adenoviruses encodes a family of late orthologous proteins that vary in their predicted structural features and subcellular localization.

Authors:  Kathryn M Frietze; Samuel K Campos; Adriana E Kajon
Journal:  J Virol       Date:  2010-08-25       Impact factor: 5.103

2.  Genome type analysis of 480 isolates of adenovirus types 1, 2, and 5.

Authors:  T Adrian; J Sassinek; R Wigand
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

3.  Molecular epidemiology and restriction site mapping of adenovirus 7 genome types.

Authors:  T Adrian; M Becker; J C Hierholzer; R Wigand
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

4.  Genome type analysis of adenoviruses: isolates from one year from the Hannover area.

Authors:  T Adrian; R Wigand; K W Knocke; G Schäfer; M Grundmann
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

5.  Serological and biochemical characteristics of intermediate adenovirus strains of subgenus D.

Authors:  T Adrian; R Wigand; G Wadell
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

6.  Genome variation of 5 clinical adenovirus type 2 isolates determined by restriction enzyme digestion analysis. Brief report.

Authors:  E S McFarlane; J H Stewart; H James
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

7.  DNA restriction analysis of adenovirus prototypes 1 to 41.

Authors:  T Adrian; G Wadell; J C Hierholzer; R Wigand
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

8.  Quantitative real-time PCR assay panel for detection and type-specific identification of epidemic respiratory human adenoviruses.

Authors:  Xiaoyan Lu; Elizabeth Trujillo-Lopez; Lisa Lott; Dean D Erdman
Journal:  J Clin Microbiol       Date:  2013-01-16       Impact factor: 5.948

Review 9.  Molecular epidemiology of adenovirus type 7 in the United States, 1966-2000.

Authors:  Dean D Erdman; Wanhong Xu; Susan I Gerber; Gregory C Gray; David Schnurr; Adriana E Kajon; Larry J Anderson
Journal:  Emerg Infect Dis       Date:  2002-03       Impact factor: 6.883

10.  Human lung innate immune cytokine response to adenovirus type 7.

Authors:  Wenxin Wu; J Leland Booth; Elizabeth S Duggan; Krupa B Patel; K Mark Coggeshall; Jordan P Metcalf
Journal:  J Gen Virol       Date:  2010-01-13       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.